• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在用聚乙二醇化赛妥珠单抗维持治疗期间类风湿性间质性肺病的急性加重

Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.

作者信息

Migita Kiyoshi, Tsuji Yoshika, Hisatomi Keiko, Shigeno Riyoko, Izumi Yasumori, Iwanaga Nozomi, Koga Tomohiro

机构信息

a Department of Rheumatology and Clinical Research Center , Nagasaki Medical Center , Omura, Nagasaki , Japan.

b Department of Respiratory Medicine , Nagasaki Medical Center , Omura, Nagasaki , Japan.

出版信息

Mod Rheumatol. 2017 Nov;27(6):1079-1082. doi: 10.3109/14397595.2015.1059008. Epub 2015 Jul 20.

DOI:10.3109/14397595.2015.1059008
PMID:26044288
Abstract

We report a case involving a 68-year-old woman with rheumatoid arthritis (RA) with acute exacerbated interstitial lung disease (ILD) during certolizumab pegol maintenance therapy. She recovered quickly with steroid pulse therapy and was discharged without deterioration of basal pulmonary function. Immunoblot analysis demonstrated the circulating cleaved interleukin-1β at the phase of acute exacerbation of RA-associated ILD (RA-ILD) in this patient. The findings from this case suggested that the Nod-like receptor pyrin domain-containing protein 3 inflammasome is implicated in acute RA-ILD exacerbation.

摘要

我们报告了一例病例,患者为一名68岁患有类风湿性关节炎(RA)的女性,在聚乙二醇化赛妥珠单抗维持治疗期间出现急性加重的间质性肺疾病(ILD)。她通过类固醇冲击疗法迅速康复,出院时基础肺功能未恶化。免疫印迹分析显示,该患者在类风湿性关节炎相关间质性肺疾病(RA-ILD)急性加重期循环中存在裂解的白细胞介素-1β。该病例的研究结果表明,含Nod样受体吡啉结构域蛋白3炎性小体与RA-ILD急性加重有关。

相似文献

1
Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.在用聚乙二醇化赛妥珠单抗维持治疗期间类风湿性间质性肺病的急性加重
Mod Rheumatol. 2017 Nov;27(6):1079-1082. doi: 10.3109/14397595.2015.1059008. Epub 2015 Jul 20.
2
A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.一例类风湿关节炎患者在接受托珠单抗治疗期间发生间质性肺病急性加重导致的致命病例。
Rheumatol Int. 2012 Dec;32(12):4023-6. doi: 10.1007/s00296-010-1525-z. Epub 2010 May 18.
3
Efficacy of certolizumab pegol: a case study in a patient with rheumatoid arthritis on maintenance hemodialysis.聚乙二醇化赛妥珠单抗的疗效:一名维持性血液透析类风湿关节炎患者的病例研究
Rheumatol Int. 2015 Sep;35(9):1601-2. doi: 10.1007/s00296-015-3225-1. Epub 2015 Feb 3.
4
Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.类风湿关节炎患者使用托珠单抗治疗期间疾病活动与间质性肺疾病急性加重的相关性:一项回顾性病例对照研究。
Rheumatol Int. 2016 Jun;36(6):881-9. doi: 10.1007/s00296-016-3478-3. Epub 2016 Apr 12.
5
Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.聚乙二醇化赛妥珠单抗:炎症性自身免疫性疾病综述
BioDrugs. 2016 Dec;30(6):607-617. doi: 10.1007/s40259-016-0197-y.
6
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.类风湿关节炎相关间质性肺疾病(RA-ILD):甲氨蝶呤与肺部疾病严重程度与预后相关。
Clin Rheumatol. 2017 Jul;36(7):1493-1500. doi: 10.1007/s10067-017-3707-5. Epub 2017 Jun 6.
7
Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.类风湿关节炎患者使用抗TNF-α药物治疗一年后影像学表现、实验室及功能参数的演变
Clin Exp Rheumatol. 2017 Jan-Feb;35(1):43-52. Epub 2016 Oct 27.
8
Certolizumab pegol was effective for treating residual synovitis after total knee arthroplasty in a patient with rheumatoid arthritis: therapeutic monitoring by ultrasound.赛妥珠单抗聚乙二醇化对类风湿关节炎患者全膝关节置换术后残留滑膜炎有效:超声治疗监测
J Med Ultrason (2001). 2018 Apr;45(2):371-374. doi: 10.1007/s10396-017-0806-5. Epub 2017 Jul 19.
9
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice.聚乙二醇化赛妥珠单抗治疗类风湿关节炎的疗效与安全性:满足日常临床实践中风湿病学家的需求
BioDrugs. 2014 Apr;28 Suppl 1:S25-37. doi: 10.1007/s40259-013-0065-y.
10
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.依奇珠单抗与阿达木单抗治疗类风湿关节炎的头对头比较:来自随机 EXXELERATE 研究的 2 年疗效和安全性结果。
Lancet. 2016 Dec 3;388(10061):2763-2774. doi: 10.1016/S0140-6736(16)31651-8. Epub 2016 Nov 15.

引用本文的文献

1
Molecular mechanism of quercetin in treating RA-ILD based on network pharmacology, molecular docking, and experimental validation.基于网络药理学、分子对接和实验验证的槲皮素治疗类风湿关节炎相关间质性肺病的分子机制
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):3077-3092. doi: 10.1007/s00210-023-02772-3. Epub 2023 Oct 25.
2
Better Safe than Sorry: Rheumatoid Arthritis, Interstitial Lung Disease, and Medication-A Narrative Review.宁求稳妥,不抱遗憾:类风湿关节炎、间质性肺疾病与药物——一篇叙述性综述
Biomedicines. 2023 Jun 19;11(6):1755. doi: 10.3390/biomedicines11061755.
3
Acute exacerbation of interstitial lung disease associated with rheumatic disease.
与风湿性疾病相关的间质性肺疾病急性加重。
Nat Rev Rheumatol. 2022 Feb;18(2):85-96. doi: 10.1038/s41584-021-00721-z. Epub 2021 Dec 7.
4
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.类风湿关节炎相关间质性肺疾病的治疗:光明与阴影
J Clin Med. 2020 Apr 10;9(4):1082. doi: 10.3390/jcm9041082.
5
Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?肿瘤坏死因子抑制剂对类风湿关节炎间质性肺疾病的影响:天使还是魔鬼?
Drug Des Devel Ther. 2019 Jul 1;13:2111-2125. doi: 10.2147/DDDT.S204730. eCollection 2019.